Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.
Saved in:
| Title: | Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience. |
|---|---|
| Authors: | Angotzi F; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Lessi F; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Leoncin M; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venice, Italy., Filì C; Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata Friuli Centrale (ASUFC), Udine, Italy., Endri M; Hematology Section, Dipartimento di Medicina Specialistica, Ca' Foncello Hospital, Treviso, Italy., Lico A; Hematology and Cell Therapy Division, San Bortolo Hospital, Vicenza, Italy., Visentin A; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Pravato S; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Candoni A; Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata Friuli Centrale (ASUFC), Udine, Italy., Trentin L; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Gurrieri C; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Apr 12; Vol. 14, pp. 1370405. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
